Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

ROCHE FARMACEUTICA QUIMICA LDA

NIF 500233810
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €22,898,653 116 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €22,898,653 116 contracts
A2 · Late Publication €23,078,598,063 6,331 contracts
Contract published to BASE more than 10 days after the signing date
LOW €23,078,598,063 6,331 contracts
A5 · Threshold Splitting €26,112,774 266 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €26,112,774 266 contracts
A6 · Low Competition €130,757,094 93 contracts
Only one bidder participated in a competitive procedure
MEDIUM €130,757,094 93 contracts
A9 · Price Overrun €55,233 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €55,233 1 contracts
A9 · Abnormal Price Reduction €26,319,014,877 1,873 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €26,319,014,877 1,873 contracts
C3 · Missing Mandatory Fields €35,643,635 96 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €35,643,635 96 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

899
€3,868,347,887
159
€1,587,118,832
259
€879,737,792
150
€866,312,888
618
€846,372,143
306
€841,593,275
70
€834,639,457
1,000
€791,977,813
24
€770,392,816
103
€765,674,331
38
€747,275,352
81
€742,372,527
367
€698,589,811
524
€669,957,258
73
€661,866,242
45
€651,950,632
50
€623,265,140
37
€605,733,844
338
€604,344,776
444
€600,743,498
Page 1 of 4 · 69 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 1 contracts

NP PERTUZUMAB ROCHE
PT · 5596cdd8a8121a26b865 · Ajuste direto
A2 · Late Publication A9 · Price Overrun
€55,233 2015-04-22
Overview
Total Value Won
€26,981,433,453
Contracts Won
8,787
Score 290915 · CRITICAL RISK
NIF
500233810
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned